AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 279: F646-F654, 2000;
0363-6127/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (20)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singh, L. P.
Right arrow Articles by Crook, E. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singh, L. P.
Right arrow Articles by Crook, E. D.
Vol. 279, Issue 4, F646-F654, October 2000

Hexosamine regulation of glucose-mediated laminin synthesis in mesangial cells involves protein kinases A and C

Lalit P. Singh1 and Errol D. Crook1,2

1 Division of Nephrology, Department of Medicine, University of Mississippi Medical Center and the 2 G. V. "Sonny" Montgomery Veterans Affairs Medical Center, Jackson, Mississippi 39216-4505

Hyperglycemia leads to alterations in mesangial cell function and extracellular matrix (ECM) protein accumulation. These adverse effects of glucose may be mediated by glucose metabolism through the hexosamine biosynthesis pathway (HBP). The HBP converts fructose-6-phosphate to glucosamine-6-phosphate via the rate-limiting enzyme, glutamine:fructose-6-phosphate amidotransferase (GFA). We have investigated the effects of high glucose (HG, 25 mM) and glucosamine (GlcN, 1.5 mM) on the synthesis of the ECM protein laminin in a SV-40-transformed rat kidney mesangial (MES) cell line. The roles of protein kinases C (PKC) and A (PKA) in mediating laminin accumulation were also investigated. Treatment of MES cells with HG or GlcN for 48 h increased laminin levels in cellular extracts more than twofold compared with 5 mM glucose (low glucose; LG). The presence of the GFA inhibitor diazo-oxo-norleucine (DON, 10 µM) blocked HG but not GlcN-induced laminin synthesis. HG resulted in a time-dependent increase in total PKC and PKA activities, 57±11.3 (P < 0.01 vs. LG) and 85±17.4% (P < 0.01 vs. LG), respectively. GlcN had no effect on the total PKC activity; however, both glucose and glucosamine increased membrane-associated PKC activity by twofold compared with LG. GlcN stimulated total PKA activity by 47±8.4% (P < 0.01 vs. LG). Similarly, membrane- associated PKA activity was also increased by HG and GlcN ~1.8 and 1.5-fold, respectively. HG and GlcN increased cellular cAMP levels 2.2- and 3.4-fold, respectively. Pharmacological downregulation of PKC by long-term incubation of MES cells with 0.5 µM phorbol 12-myristate 13-acetate (PMA) or inhibition of PKA activity by 2 µM H-8 blocked the effects of HG and GlcN on laminin synthesis. These results demonstrate that glucose-induced laminin synthesis in MES cells is mediated by flux through the HBP and that this stimulation involves PKC and PKA signaling pathways.

diabetic nephropathy; laminin; hexosamine biosynthesis pathway


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
L. P. Singh, K. Green, M. Alexander, S. Bassly, and E. D. Crook
Hexosamines and TGF-{beta}1 use similar signaling pathways to mediate matrix protein synthesis in mesangial cells
Am J Physiol Renal Physiol, February 1, 2004; 286(2): F409 - F416.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
L. P. Singh, J. Andy, V. Anyamale, K. Greene, M. Alexander, and E. D. Crook
Hexosamine-Induced Fibronectin Protein Synthesis in Mesangial Cells Is Associated With Increases in cAMP Responsive Element Binding (CREB) Phosphorylation and Nuclear CREB: The Involvement of Protein Kinases A and C
Diabetes, October 1, 2001; 50(10): 2355 - 2362.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online